Is American Healthcare REIT, Inc. (AHR) Stock Outpacing Its Finance Peers This Year?
Here is how American Healthcare REIT (AHR) and Alerus (ALRS) have performed compared to their sector so far this year.
American Healthcare REIT Is Capitalizing On Extremely Favorable Fundamentals
American Healthcare REIT is positioned to benefit from a multi-year supply-demand imbalance in senior housing, supporting robust occupancy and rent growth. AHR's double-digit NFFO and SPNOI growth, combined with a healthy acquisition pipeline and declining leverage, underpin expectations for mid-teens total returns. Trading at ~24x 2026 NFFO, AHR is a value play among senior housing REITs, with a well-covered 2% dividend yield and strong organic and external growth prospects.
Jefferies updates its list of highest-conviction Buy-rated stocks
Jefferies, an investment banking and capital management firm, has updated its ‘Franchise Picks' list, which features the company's highest-conviction ‘Buy' rated stocks.
American Healthcare REIT Q1 Earnings Call Highlights
American Healthcare REIT NYSE: AHR raised its 2026 outlook after reporting another quarter of double-digit same-store net operating income growth, supported by strength in its Trilogy integrated senior health campus business and senior housing operating portfolio.
American Healthcare REIT, Inc. (AHR) Q1 2026 Earnings Call Transcript
American Healthcare REIT, Inc. (AHR) Q1 2026 Earnings Call Transcript
Is American Healthcare REIT, Inc. (AHR) Outperforming Other Finance Stocks This Year?
Here is how American Healthcare REIT (AHR) and Bank of Nova Scotia (BNS) have performed compared to their sector so far this year.
Algert Global LLC Purchases 299,075 Shares of American Healthcare REIT, Inc. $AHR
Algert Global LLC increased its position in shares of American Healthcare REIT, Inc. (NYSE: AHR) by 277.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 406,897 shares of the company's stock after purchasing an additional 299,075 shares during
American Healthcare REIT Upgraded As Its Portfolio Grows While Leverage Risk Falls
American Healthcare REIT is upgraded to Buy, driven by robust portfolio growth, favorable macro trends, and strong FFO/NOI performance. AHR's diversified US/UK portfolio, low leverage (D/E 0.50), and expanding development pipeline position it well versus peers. Despite weaker EBITDA margins and modest dividend yield (1.9%), AHR's price forecasts and analyst consensus support upside.
5 of Bank of America's US1 List Top Picks Also Pay Big Passive Income
Most dividend investors seek solid passive income streams from quality dividend stocks.
American Healthcare REIT, Inc. (AHR) Presents at Citi's Miami Global Property CEO Conference 2026 Transcript
American Healthcare REIT, Inc. (AHR) Presents at Citi's Miami Global Property CEO Conference 2026 Transcript
American Healthcare REIT, Inc. (AHR) Q4 2025 Earnings Call Transcript
American Healthcare REIT, Inc. (AHR) Q4 2025 Earnings Call Transcript
Property Type Round-Up From REITWorld 2025
REITs are positioned for robust growth in 2026, driven by decelerating supply, disciplined capital allocation, and significant valuation discounts to NAV and private markets. Sector preferences favor Healthcare and Data Centers for durable growth, with Shopping Centers and select Residential REITs offering underappreciated upside and private capital interest. Strategic alternatives, buybacks, and targeted M&A are increasingly in focus, especially for deeply discounted names like CSR, WSR, COLD, and REXR.
